Stories about Chemie
- 2One documentmore
- 2
Adaptability for reliable separation processes with GEA Varipond C
2 Documentsmore Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic
London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...
moreIsomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic
London (ots/PRNewswire) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 ...
more- 4
Press Release - hubergroup Chemicals Presents Groundbreaking Bio-Based UV Oligomers at the European Coatings Show 2025 at its Booth and in a Presentation
One documentmore - 3
“Best CO₂ Utilisation 2025”: Celebrating Pioneering Innovation in Carbon Capture and Utilisation Technologies
One documentmore
- 5
GEA Direct Sprayer DS 25: Less Water, Faster Cleaning
One documentmore LAUDA DR. R. WOBSER GMBH & CO. KG
LAUDA honors Theo Schlegelmilch for 40 years with the company
morePM: Alexion und DHL Express setzen in Irland auf SAF für internationale Luftfrachtlieferung von Medikamenten / PR: Alexion and DHL Express Join Forces in Ireland’s First 100% Switch to SAF for International Air Delivery of Medicines
more- 6
CO₂ Revolution 2025: Fueling the Future, Capturing Possibilities
One documentmore PM: DHL Group und Neste vertiefen Zusammenarbeit zur Senkung von Emissionen in der Logistik / PR: DHL Group and Neste to tighten collaboration to reduce logistics emissions
more- 8
Press Release - hubergroup unveils revolutionary DYNAMICA Ink Series
One documentmore
FCL Components Officially Releases ATEX-Approved Relays
moreX4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.
London (ots/PRNewswire) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare ...
morePekutherm Positioned for Success in 2025
Pekutherm Positioned for Success in 2025 - Pekutherm Kunststoffe GmbH has embodied sustainability from the very beginning. - As a partner of the Europe-wide Recycling Alliance founded by Röhm, Pekutherm makes an important contribution to the circular economy. - Pekutherm is expanding its recycling capacity and strengthening its presence in European markets to meet growing demand. - Through recycling partnerships such as ...
moreMore sustainable fuels: GEA wins first customer for Pre2Fuel process
2 DocumentsmorePress release: Symbolic start of industrial heat feed-in to Hamburg city network
One documentmoreNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
more
- 25
Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality
more LAUDA DR. R. WOBSER GMBH & CO. KG
Antonio Manconi Ten Years With LAUDA Italia
more- 6
Transforming CO₂ into Opportunities: The CO₂-Based Fuels and Chemicals Conference 2025
One documentmore Obrist Anticipates a Pivotal Shift Towards "Liquid Solar Energy" in 2025
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreAccord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®
London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...
more
Obrist Group Introduces Alternatives to PFAS and F-Gases
Obrist Group Introduces Alternatives to PFAS and F-Gases Natural Refrigerants Replacing Harmful Forever Chemicals in Cars Lindau/Germany, Lustenau/Austria – December 10 2024 – Per- and polyfluoroalkyl substances (PFAS) are recognized as highly hazardous, and the European Union is preparing to ban these toxic chemicals. The PFAS group also includes F-gases, such as hydrofluorocarbons, which are widely used in cooling ...
moreTechnische Universität München
Removing hazardous PFAS chemicals from drinking water
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM researchers develop highly effective filter material Removing hazardous PFAS chemicals from drinking water - Metal-organic framework compounds made of zirconium carboxylate as filters - Large-scale use in practice still to come - Contaminated sites caused by PFAS will be with us for several generations ahead The chemicals known as PFAS are considered a severe threat to ...
moreObrist Group: Methanol as the Ideal Fossil Fuel Replacement for Key Industries
moreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
more- 6
Capture, Convert, and Conquer: Innovations Wanted for the “Best CO₂ Utilisation 2025” Innovation Award
One documentmore Press release: Aurubis investing € 40 million in more independent and efficient production in Lünen
One documentmore